Early treatment with approaches like omega-3 supplementation and exercise may allow nerves to regenerate
(8) As shown in Fig
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
Jo M, Lee S, Jeon YM, Kim S, Kwon Y, Kim HJ
First, sourcing is everything
As shown in Supplementary Figure 1, we did not observe a significant difference in the cell number between the control and ABT263 treatment group
